Excelra
Share
The Excelra Edge comes from a seamless amalgamation of proprietary curated data assets, deep domain expertise and data science. The company's multifaceted teams harmonize and analyze large volumes of disparate unstructured data using cutting-edge technologies. We galvanize data-driven decisions to unlock operational efficiencies to accelerate drug discovery and development. Over the past 18 years,
Drug discovery teams don’t struggle with a lack of genetic data.
They struggle with too much of it, spread across GWAS studies, PheWAS datasets, locus reports, and siloed research systems that rarely connect seamlessly. https://na2.hubs.ly/H05mwqJ0
Excelra solved this by building a Target Assessment Platform that unified genetic evidence, automated locus-level reporting, and enabled rapid target prioritisation through intelligent annotation workflows.
The result? Faster shortlisting, stronger genetic validation, and a scalable foundation for evidence-driven drug discovery.
07/05/2026
What if the next breakthrough in precision oncology was hidden across fragmented molecular and clinical data, waiting to be connected?
Excelra developed an LLM-powered multimodal oncology data analysis platform that unified genomics, ctDNA, methylation profiles, EHRs, and claims data into a single, insight-driven ecosystem. Read the full case study: https://na2.hubs.ly/H05lnJF0
By combining advanced AI, contrastive learning, explainable analytics, and knowledge graphs, the platform enabled:
- 2–3× faster biomarker discovery
- 30–50% improvement in research efficiency
- Real-time analytics and hypothesis generation
The result? A scalable, future-ready foundation for GenAI-enabled precision oncology research.
Click here to claim your Sponsored Listing.
Category
Telephone
Website
Address
7th Floor Wing B
Uppal
500039
Opening Hours
| Monday | 9am - 6pm |
| Tuesday | 9am - 6pm |
| Wednesday | 9am - 6pm |
| Thursday | 9am - 6pm |
| Friday | 9am - 6pm |
